Fransvea E - Search Results

1

Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation.

Mazzocca A, Fransvea E, Lavezzari G, Antonaci S, Giannelli G. Mazzocca A, et al. Among authors: fransvea e. Hepatology. 2009 Oct;50(4):1140-51. doi: 10.1002/hep.23118. Hepatology. 2009. PMID: 19711426

2

Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.

Giannelli G, Fransvea E, Marinosci F, Bergamini C, Colucci S, Schiraldi O, Antonaci S. Giannelli G, et al. Among authors: fransvea e. Am J Pathol. 2002 Jul;161(1):183-93. doi: 10.1016/s0002-9440(10)64170-3. Am J Pathol. 2002. PMID: 12107103 Free PMC article.

3

Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells.

Fransvea E, Angelotti U, Antonaci S, Giannelli G. Fransvea E, et al. Hepatology. 2008 May;47(5):1557-66. doi: 10.1002/hep.22201. Hepatology. 2008. PMID: 18318443

4

Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma.

Fransvea E, Mazzocca A, Antonaci S, Giannelli G. Fransvea E, et al. Hepatology. 2009 Mar;49(3):839-50. doi: 10.1002/hep.22731. Hepatology. 2009. PMID: 19115199

5

HCC heterogeneity: molecular pathogenesis and clinical implications.

Fransvea E, Paradiso A, Antonaci S, Giannelli G. Fransvea E, et al. Cell Oncol. 2009;31(3):227-33. doi: 10.3233/CLO-2009-0473. Cell Oncol. 2009. PMID: 19478390 Free PMC article.

6

Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma.

Mazzocca A, Fransvea E, Dituri F, Lupo L, Antonaci S, Giannelli G. Mazzocca A, et al. Among authors: fransvea e. Hepatology. 2010 Feb;51(2):523-34. doi: 10.1002/hep.23285. Hepatology. 2010. PMID: 19821534

7

Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study.

Fransvea E, Mazzocca A, Santamato A, Azzariti A, Antonaci S, Giannelli G. Fransvea E, et al. Cancer Chemother Pharmacol. 2011 Jul;68(1):79-86. doi: 10.1007/s00280-010-1459-x. Epub 2010 Sep 16. Cancer Chemother Pharmacol. 2011. PMID: 20844878

8

Inhibiting TGF-β signaling in hepatocellular carcinoma.

Giannelli G, Mazzocca A, Fransvea E, Lahn M, Antonaci S. Giannelli G, et al. Among authors: fransvea e. Biochim Biophys Acta. 2011 Apr;1815(2):214-23. doi: 10.1016/j.bbcan.2010.11.004. Epub 2010 Dec 1. Biochim Biophys Acta. 2011. PMID: 21129443 Review.

9

Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.

Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S. Giannelli G, et al. Among authors: fransvea e. Gastroenterology. 2005 Nov;129(5):1375-83. doi: 10.1053/j.gastro.2005.09.055. Gastroenterology. 2005. PMID: 16285938

10

Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma.

Giannelli G, Bergamini C, Marinosci F, Fransvea E, Quaranta M, Lupo L, Schiraldi O, Antonaci S. Giannelli G, et al. Among authors: fransvea e. Int J Cancer. 2002 Feb 1;97(4):425-31. doi: 10.1002/ijc.1635. Int J Cancer. 2002. PMID: 11802202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters